Navigation Links
Aspira Scientific Introduces Xeno-free rHSA Product at World Stem Cell Summit

SAN FRANCISCO, Dec. 5, 2013 /PRNewswire/ -- Aspira Scientific, Inc., a research and development solutions provider for the chemical and biological sectors, today announces the official launch of its recombinant Human Serum Albumin (rHSA) product. Aspira Scientific's highly pure, cost-effective rHSA is produced from a proprietary expression technology platform, originating from rice grains (Oryza sativa) and is more than 99 percent devoid of any animal, human, or micro-organism derived components ("xeno-free"). To learn more about rHSA, visit


Produced by the innovative plant-based protein technology pioneered by Dr. Daichang Yang of Healthgen Biotechnology Co., Ltd., rHSA has the same application fields as plasma-derived Human Serum Albumin (pHSA), but offers a higher purity, more consistent, xeno-free replacement that can be manufactured to scale. Aspira Scientific's rHSA is made more cost-effectively and safely than other rHSA products, avoiding immunogenicity concerns of rHSA produced in yeast-based expression systems.

"We are proud to collaborate with our strategic manufacturing partner, Healthgen Biotechnology, to offer this ultra-pure, yet highly affordable rHSA for the research market," said Dr. John Chan, CEO, Aspira Scientific. "Our rHSA will fuel innovations in quality-demanding applications such as stem cell therapy, targeted drug delivery, and medical device coating; as well as decrease costs dramatically in high-volume applications such as cell culture media development."

Aspira Scientific's rHSA is manufactured in an ISO 9001 certified facility with rigorous quality control and superior batch-to-batch consistency. The product complies with global regulatory recommendations for non-animal derived components for pharmaceutical related research and development and is available in small-to-large scale commercial quantities.

About Aspira Scientific
Aspira Scientific empowers scientists to achieve their aspirations in chemical and biological research and development by reducing the costs of basic and applied research. The company leverages a global innovation ecosystem to offer a wide array of next-generation enabling research tools. For organizations with developmental programs and commercial intent, Aspira Scientific provides user-driven services via a "Collaborate Locally. Commercialize Globally."™ model to afford exceptional value in terms of innovation, quality and IP assurance, and cost efficiency. For more information, visit

Dianne Needham
Marketing Communications

SOURCE Aspira Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Hajarian New Surgical Retractor/Aspirator May Revoultionize Surgical Retractors
2. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
3. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
4. Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering
5. Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
6. One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
7. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
8. Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent
9. Generex Augments Antigen Express Scientific Advisory Board
10. Receptos to Deliver Scientific Presentation at Digestive Disease Week 2012 about the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease
11. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
Post Your Comments:
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Care Market by Type (Dressings, Therapy Devices, Active Wound ... Out-Patient Facility), and Geography - Global Forecast to 2020" ... --> --> The purpose of this ... of the global advanced wound care market. It involves ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... of the "Self Administration of High Viscosity ... ) has announced the addition of ... report to their offering. --> ... the addition of the "Self Administration of ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
Breaking Medicine Technology:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... gatherings where preparing the perfect dish and pleasing the palates of attendees is ... or bringing a dish to a seasonal get-together, give these recipes a try ...
(Date:11/25/2015)... ... 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever ... with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the ... the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article ... more and more widely heralded as a breakthrough for performing hernia repairs. The article ... traditional laparoscopic surgery is that it can greatly reduce the pain that a patient ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... and athletic programs, launches new Wimbledon Athletics Facebook page to educate ... athletes for unsuspected cardiac abnormalities. About 2,000 people under the age of 25 ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) ... plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion of ... Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for his ...
Breaking Medicine News(10 mins):